News & Announcements
Dr Soumya Swaminathan joins Ignite Life Science Foundation as SAB
A globally recognized physician-scientist in the area of tuberculosis and HIV
Dr Soumya Swaminathan joins Ignite Life Science Foundation as Scientific Advisor
A globally recognized physician-scientist in the area of tuberculosis and HIV, Dr Swaminathan brings with her 30 years of experience in research, clinical care, policy and translation of research into impactful programmes. She was most recently Chief Scientist and before that, Deputy Director-General for Programmes at the World Health Organization. Prior to that, Dr Swaminathan was Secretary to the Government of India for Health Research and Director General of the Indian Council of Medical Research (2015 to 2017). In these positions, she brought science and evidence into health policy-making, building research capacity, and forging international partnerships in health sciences.
Welcoming her to Ignite, Dr Shahid Jameel, Scientific Advisor and Founding Member, said: “Soumya is a globally recognised research leader, who will add value to Ignite’s scientific advisory board. We will count on her technical expertise and understanding of the health policy and funding networks to promote Ignite’s mission of improving the impact of Indian life sciences research. I am pleased to have the opportunity to work with her again.
Dr Soumya Swaminathan said – “I am delighted to join the eminent group of advisors at Ignite and look forward to working with them to drive what I believe is a critical agenda for India – to support the Indian life sciences community to achieve excellence.”
Dr. T. S. Balganesh Joins Ignite as scientific advisor
We are pleased to announce that Dr T S Balganesh is joining Ignite as Scientific Advisor. Dr Balganesh is an experienced drug discovery scientist and has led pharmaceutical R&D and public sector initiatives in Open Source Drug Discovery. We are very happy that he agreed to join us to help us in our mission to promote life science research in India. He is a valuable addition to an already stellar team of advisors. We welcome him on board.